- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02120586
Preventive Physiotherapy Intervention in Elderly People With Sarcopenia
Effects and Costs of Preventive Physiotherapy Intervention in Institutionalized Elderly People With Sarcopenia: A Randomized Controlled Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Sarcopenia is a syndrome characterized by progressive and generalized loss of skeletal muscle mass and strength with a risk of adverse outcomes such as physical disability, poor quality of life and death (Goodpaster et al, 2006; Delmonico et al, 2007). The contributing factors are those related to aging process, non-optimal diet, bed rest or sedentary lifestyle, chronic diseases and certain drug treatments. Most of these factors are present in the older population with comorbidity, frequently institutionalized to receive a professional long-term care.
Since the European Working Group on Sarcopenia in Older People (Cruz-Jentoft et al, 2010) recommends using the presence of both low muscle mass and low muscle function (strength and/or physical performance) for the diagnosis of sarcopenia, interventions should be focused in both criteria. The aim of this study is to prevent loss of skeletal muscle mass and strength in institutionalized elderly with sarcopenia.
To this purpose, the investigators study undertakes two physiotherapy interventions to preventing/treating Sarcopenia, namely, maintenance of muscle mass and improvement of strength in peripheral and respiratory muscles. Both interventions are common in the following features: supervision, duration, frequency and intensity of the training program.
The primary outcomes are those related to muscle mass and strength. Secondary outcomes will be related to muscle function (muscle endurance and/or physical performance), costs and health status (number of falls and fractures, exacerbations of chronic diseases, hospitalizations and deaths during the year after concluding the physiotherapy interventions).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Valencia, Spain, 46015
- Grupo Gero Residencias "La Saleta"
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- People aged > 65 years
- Sarcopenia diagnosis (Tyrovolas et al., 2015)
- Medically stable at least 2 months before the study
Exclusion Criteria:
- Cardiorespiratory, muscular, neurological, or neuromuscular disease that could interfere in the proper performance of assessment and/or training protocols.
- Endocrine and metabolic disorders that might have had an effect on muscle mass.
- Severe disorder of hydration status that could interfere in Bioelectrical Impedance Analysis (Rubbieri et al., 2014).
- A terminal disease diagnosis.
- Mini-Mental State Examination Index ≤ 20 score.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Control group
Usual care
|
|
Experimental: Respiratory training group
Participants will breathe against a load ≥ 50% of their baseline MIP, after which loads will increase according to the participant's tolerance across the remaining training period, using a Borg scale rating of 4 to 6 on perceived exertion as an indicator of adequate training intensity. Intervention: Inspiratory Muscle training (12-weeks) |
Supervised interval-based program consisting of seven cycles of 2-minutes work and 1-minute rest. This protocol is published as a practical guide for clinicians by Hill et al (2010). The sessions will take place 3 times per week over a twelve-week period for a total of 36 sessions. All participants will be familiarized with the breathing exercises over a two-week familiarization period at the beginning of the protocol. The load will be adjusted at ≥ 50% of baseline MIP. Participants remain seated in groups of 8 to 10.
Other Names:
|
Experimental: Peripheral training group
Participants will load ≥ 50% of their maximum muscle force (Kg), after which load will increase according to the participant's tolerance across the remaining training period, using a Borg scale rating of 4 to 6 on perceived exertion as an indicator of adequate training intensity. Intervention: Peripheral muscle training (12-weeks) |
The supervised training program consists of one cycle of 10 exercises, 12 repetitions each one. The main peripheral muscles to be trained will be those recommended by Cruz-Jentoft et al (2011): brachial biceps and triceps, pectorals, deltoid, hand flexors and extensors, spine extensor muscles, psoas-iliac, quadriceps femoris and sural triceps. The sessions will take place 3 times per week over a twelve-week period for a total of 36 sessions. All participants were familiarized with the force exercises over a two-week familiarization period at the beginning of the protocol. The load will be adjusted at ≥ 50% of maximum muscle force. Participants remain seated in groups of 8 to 10. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Muscle mass
Time Frame: The groups will be assessed at baseline (pre-intervention) and at the end of the training program (week 12, post-intervention).
|
Bioimpedance analysis (BIA) estimates the volume of fat and lean body mass.
The test itself is inexpensive, easy to use, readily reproducible and appropriate for both ambulatory and bedridden patients.
Reference: J Aging Phys Act 2015;23(4):597-606.
Korean J Intern Med 2016;31:643-650.
|
The groups will be assessed at baseline (pre-intervention) and at the end of the training program (week 12, post-intervention).
|
Change in Maximum Respiratory Pressures (MIP and MEP)
Time Frame: The groups will be assessed at baseline (pre-intervention) and at the end of the training program (week 12, post-intervention).
|
MIP and MEP are probably the most frequently reported non-invasive estimates of respiratory muscle strength.
Ever since Black and Hyatt (1969) reported this technique it has been widely used in patients, healthy control subjects across all ages, and athletes.
Pressure is recorded at the mouth during a quasi-static short (few seconds) maximal breathing.
Reference: Am J Respir Crit Care Med.
2002;166:531-535.
|
The groups will be assessed at baseline (pre-intervention) and at the end of the training program (week 12, post-intervention).
|
Change in Handgrip strength
Time Frame: The groups will be assessed at baseline (pre-intervention) and at the end of the training program (week 12, post-intervention).
|
Isometric hand grip strength is strongly related with lower extremity muscle power, knee extension torque and calf cross-sectional muscle area.
In practice, there is also a linear relationship between baseline handgrip strength and incident disability for activities of daily living.
Reference: Age and Aging.
2010;39:412-423.
|
The groups will be assessed at baseline (pre-intervention) and at the end of the training program (week 12, post-intervention).
|
Change in peripheral muscle strength
Time Frame: The groups will be assessed at baseline (pre-intervention) and at the end of the training program (week 12, post-intervention).
|
Maximal isometric muscle strength (Kg) was assessed for knee extension (Quadriceps femoris) and elbow flexion (Biceps brachii).
Reference: J Am Geriatr Soc 2002; 50: 461-7.
|
The groups will be assessed at baseline (pre-intervention) and at the end of the training program (week 12, post-intervention).
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Maximal Voluntary Ventilation (MVV)
Time Frame: The groups will be assessed at baseline (pre-intervention) and at the end of the training program (week 12, post-intervention).
|
This ventilatory test is a non-invasive technique and is a measure of both inspiratory and expiratory muscle endurance.
The MVV is the largest volume that can be breathed in and out of the lungs during a 12 -15 second interval with maximal voluntary effort.
Reference: Am J Respir Crit Care Med.
2002;166:562-564.
|
The groups will be assessed at baseline (pre-intervention) and at the end of the training program (week 12, post-intervention).
|
Change in Time performed to walk 10 m distance (10mWT).
Time Frame: The groups will be assessed at baseline (pre-intervention) and at the end of the training program (week 12, post-intervention).
|
The 10-Meter Walk Test (10mWT) is a measure of gait speed (measurement of physical performance).
The walking course consist of 14 m in a hallway: a 2 m warm-up, 10 m use for the speed measurement, and 2 m for slowing down to stop.
Participants can use the assistive device (eg, cane, walker) or orthotic device (eg, ankle-foot orthosis) that they use "most often" (if any) at each time point.
Reference: Phys Ther.
2010;90(2):196-208.
|
The groups will be assessed at baseline (pre-intervention) and at the end of the training program (week 12, post-intervention).
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Falls and fractures
Time Frame: Intervention costs will be recorded from the time zero to 12-weeks.
|
Number of falls and resulting fractures will be checked from the medical history of participants.
|
Intervention costs will be recorded from the time zero to 12-weeks.
|
Intervention costs
Time Frame: Intervention costs will be recorded from the time zero to 12-weeks.
|
Intervention costs related to staff (supervision of training programs), consumables (Threshold IMT and weights-ballasts) and capital for intervention will be calculate in 2014 €.
Reference: Rev Esp Geriatr Gerontol.
2014;49:203-209.
|
Intervention costs will be recorded from the time zero to 12-weeks.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Maria A Cebrià i Iranzo, PT, PhD, University of Valencia
- Study Chair: María J Ponce Darós, PT, PhD, University of Valencia
Publications and helpful links
General Publications
- Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, Topinkova E, Vandewoude M, Zamboni M; European Working Group on Sarcopenia in Older People. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010 Jul;39(4):412-23. doi: 10.1093/ageing/afq034. Epub 2010 Apr 13.
- Cruz-Jentoft AJ, Triana FC, Gomez-Cabrera MC, Lopez-Soto A, Masanes F, Martin PM, Rexach JA, Hidalgo DR, Salva A, Vina J, Formiga F. [The emergent role of sarcopenia: Preliminary Report of the Observatory of Sarcopenia of the Spanish Society of Geriatrics and Gerontology]. Rev Esp Geriatr Gerontol. 2011 Mar-Apr;46(2):100-10. doi: 10.1016/j.regg.2010.11.004. Epub 2011 Jan 8. Spanish.
- Doherty TJ. Invited review: Aging and sarcopenia. J Appl Physiol (1985). 2003 Oct;95(4):1717-27. doi: 10.1152/japplphysiol.00347.2003.
- Tyrovolas S, Koyanagi A, Olaya B, Ayuso-Mateos JL, Miret M, Chatterji S, Tobiasz-Adamczyk B, Koskinen S, Leonardi M, Haro JM. The role of muscle mass and body fat on disability among older adults: A cross-national analysis. Exp Gerontol. 2015 Sep;69:27-35. doi: 10.1016/j.exger.2015.06.002. Epub 2015 Jun 3.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- H1382044172319 (Other Identifier: University of Valencia Research Ethics Committee)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- Clinical Study Report (CSR)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sarcopenia
-
University of Texas at AustinNot yet recruitingExercise Training and SarcopeniaUnited States
-
Centre Hospitalier Universitaire DijonCompleted
-
Creighton UniversityUniversity of NebraskaRecruiting
-
University Hospital, CaenCompleted
-
University of NottinghamUniversity of OxfordRecruitingMuscle Atrophy | Age-Related SarcopeniaUnited Kingdom
-
Tufts UniversityNational Institute on Aging (NIA)CompletedMuscle Loss | Age-Related SarcopeniaUnited States
-
China Medical University HospitalCompleted
-
King's College LondonCo-sponsor: Guy's and St Thomas' NHS Foundation TrustCompletedFrailty | Sarcopenia | Age-Related SarcopeniaUnited Kingdom
-
Norwegian School of Sport SciencesOslo University HospitalNot yet recruitingHealthy Aging | Testosterone Deficiency | Age-Related Sarcopenia
-
Ningbo Medical Center Lihuili HospitalCompletedHemodialysis Patients With SarcopeniaChina
Clinical Trials on Inspiratory Muscle Training (IMT).
-
Mayo ClinicNational Heart, Lung, and Blood Institute (NHLBI)CompletedBlood Pressure | Exercise Capacity | Respiratory Muscle | Sympathetic Nerve ActivityUnited States
-
Fondazione Don Carlo Gnocchi OnlusAssociazione Italiana Glicogenosi (AIG); Associazione Riabilitatori Insufficienza... and other collaboratorsRecruitingGlycogen Storage Disease Type II | Pompe Disease (Late-onset)Italy
-
Johns Hopkins UniversityNot yet recruitingPulmonary Atelectasis | Pneumonia, Ventilator-AssociatedUnited States
-
Istanbul UniversityNot yet recruiting
-
Dokuz Eylul UniversityCompletedIdiopathic Pulmonary Fibrosis | IPFTurkey
-
Central Jutland Regional HospitalSygekassernes HelsefondRecruitingRespiratory Insufficiency | Functional IndependenceDenmark
-
University of MiamiFoundation for Physical Therapy, Inc.; Craig H. Nielsen FoundationCompleted
-
Izmir Katip Celebi UniversityCompleted
-
UMC UtrechtCompletedEsophageal Resection CandidatesNetherlands, Belgium, Finland, Ireland
-
Faculdade Evangelica do ParanaCompletedChronic Obstructive Pulmonary Disease